DISEASE SCANNER
Global Incurable Diseases Tracker
Ankylosing Spondylitis
A chronic inflammatory arthritis primarily affecting the axial skeleton (spine and sacroiliac joints), causing pain, stiffness, and potential fusion. A form of spondyloarthritis. Strong association with HLA-B27. Onset typically in young adulthood.
15.0M
111
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Clinical criteria (ASAS)
- 2X-rays of sacroiliac joints
- 3MRI of sacroiliac joints and spine
- 4HLA-B27 testing
- 5Blood tests (ESR, CRP)
- 6Assessment for uveitis
- 7Assessment for IBD
Prognosis
Good functional outcome with early anti-TNF therapy. Disease-modifying therapy slows radiographic progression. 10-20% have severe disability with spinal fusion. Uveitis affects 30-40%; usually responsive to topical steroids. Cardiac involvement (aortitis) rare but serious. Osteoporosis common in spine; fracture risk increased. Regular exercise maintains mobility. Biologic therapy has transformed outcomes; 70-80% achieve ASAS40 response. Smoking cessation important. Spinal surgery rarely needed.
Prevention
- No primary prevention
- Early diagnosis and treatment
- Regular exercise
- Smoking cessation
- Good posture
- Ergonomic workplace
- Screening for associated conditions
Research Status
TNF inhibitors (infliximab, etanercept, adalimumab, golimumab, certolizumab) and IL-17 inhibitors (secukinumab, ixekizumab) highly effective. JAK inhibitors (tofacitinib, upadacitinib) approved. Biosimilars improving access. MRI early detection.
Affected Countries
Sources
- https://www.cdc.gov/
- https://www.hematology.org/education/patients
- https://www.ncbi.nlm.nih.gov/books
- https://rarediseases.org/rare-diseases
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.